TCL Archive Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends November 5, 1976
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014